|
DCAF4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.85900000007722E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.26800000002747E-07 |
| Normal-vs-Stage2 |
5.549200E-01 |
| Normal-vs-Stage3 |
3.61530000048127E-07 |
| Normal-vs-Stage4 |
1.29430022255406E-10 |
| Stage1-vs-Stage2 |
6.101300E-03 |
| Stage1-vs-Stage3 |
2.258600E-01 |
| Stage1-vs-Stage4 |
7.210900E-04 |
| Stage2-vs-Stage3 |
1.681720E-03 |
| Stage2-vs-Stage4 |
3.53470000000744E-05 |
| Stage3-vs-Stage4 |
6.864400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.84690000024379E-07 |
| Normal-vs-AfricanAmerican |
1.842200E-04 |
| Normal-vs-Asian |
2.58179999601538E-09 |
| Caucasian-vs-AfricanAmerican |
4.683400E-01 |
| Caucasian-vs-Asian |
2.091700E-02 |
| AfricanAmerican-vs-Asian |
6.667000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.05089999988562E-07 |
| Normal-vs-Female |
1.34750000002626E-06 |
| Male-vs-Female |
1.796790E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.40580002983404E-09 |
| Normal-vs-Age(41-60Yrs) |
7.76510000000119E-05 |
| Normal-vs-Age(61-80Yrs) |
5.75269999999461E-05 |
| Normal-vs-Age(81-100Yrs) |
3.419200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.787200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.950400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.710800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.951800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.586600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.872400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.138300E-03 |
| Classical-VS-Follicular |
2.035400E-04 |
| Classical-VS-Other |
4.588200E-01 |
| Classical-VS-Normal |
6.42910003012531E-09 |
| Tall-VS-Follicular |
1.23690000020105E-07 |
| Tall-VS-Other |
6.255000E-01 |
| Tall-VS-Normal |
1.22819976411392E-10 |
| Follicular-VS-Other |
8.690500E-02 |
| Follicular-VS-Normal |
1.701440E-01 |
| Other-VS-Normal |
3.956200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.038500E-03 |
| Normal-vs-N1 |
3.01270119962282E-12 |
| N0-vs-N1 |
3.25820004309918E-09 |
|
|
